Richard Douglas Purchases 80,000 Shares of MaxCyte, Inc. (NASDAQ:MXCT) Stock

MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) Director Richard Douglas acquired 80,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 29th. The stock was bought at an average price of $4.32 per share, with a total value of $345,600.00. Following the transaction, the director now directly owns 100,000 shares in the […]

Related Keywords

Blackrock ,Massachusetts ,United States ,Richard Douglas ,Massachusetts Financial Services Co ,Vanguard Group Inc ,Nasdaq ,Millennium Management ,Maxcyte Inc ,Blackrock Inc ,Get Rating ,Director Richard Douglas ,Water Life Science Advisors ,Financial Services ,Maxcyte Daily ,Maxcyte ,Nasdaq Mxct ,Mxct ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,